iOnctura’s roginolisib awarded Innovation Passport by John Pinching | Mar 28, 2023 | News | 0 MHRA designation involves entry into innovative licensing and access pathway Read More
Innovation Passport awarded Alnylam and its hypertension therapy by John Pinching | Jun 8, 2022 | News | 0 The company received the Innovation Passport in the UK for zilebesiran, an investigational treatment of hypertension Read More
bluebird bio’s sickle cell gene therapy granted MHRA ‘innovation passport’ by Lucy Parsons | Jun 30, 2021 | News | 0 Innovation passport designation scheme aims to reduce the time to market for promising treatments Read More